GENinCode: GENinCode revenue grows amid continued international expansion

(marketscreener.com) GENinCode PLC on Monday reported improved financial performance in 2023 as the company scaled up operations. The Oxford, England-based genomic testing company is focused on the prevention of cardiovascular disease and ovarian cancer. For 2023, the company said pretax loss widened to GBP7.0 million from GBP5.7 million the previous year. Revenue...https://www.marketscreener.com/quote/stock/GENINCODE-PLC-125090824/news/GENinCode-revenue-grows-amid-continued-international-expansion-46888348/?utm_medium=RSS&utm_content=20240603